Cancer risk is not increased after conventional hip arthroplasty: A nationwide study from the Finnish Arthroplasty Register with follow-up of 24,636 patients for a mean of 13 years

Acta Orthopaedica

Volumn 81, Issue 1, 2010, Pages 77-81

  Visuri, Tuomo ^a   Pulkkinen, Pekka ^b   Paavolainen, Pekka ^c   Pukkala, Eero ^c  

^a CENTRE FOR MILITARY MEDICINE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

METAL; POLYETHYLENE; METHACRYLIC ACID DERIVATIVE; POLYETHYLENE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; CHROMOSOME ABERRATION; COHORT ANALYSIS; DNA DAMAGE; FEMALE; FOLLOW UP; HIP ARTHROPLASTY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PROSTATE CANCER; REGISTER; RISK ASSESSMENT; STANDARDIZED INCIDENCE RATIO; CHEMICALLY INDUCED DISORDER; CORROSION; FINLAND; HIP OSTEOARTHRITIS; HIP PROSTHESIS; INCIDENCE; MIDDLE AGED; NEOPLASM; PROSTHESIS FAILURE; RISK FACTOR;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; COHORT STUDIES; CORROSION; FEMALE; FINLAND; FOLLOW-UP STUDIES; HIP PROSTHESIS; HUMANS; INCIDENCE; MALE; METALS; METHACRYLATES; MIDDLE AGED; NEOPLASMS; OSTEOARTHRITIS, HIP; POLYETHYLENES; PROSTHESIS FAILURE; REGISTRIES; RISK FACTORS;

EID: 77950466231     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453671003667150     Document Type: Article

References (41)

1. Anttila A, Pukkala E, Aitio A, Rantanen T, Karjalainen S. Update of cancer incidence among workers at a copper/nickel smelter and nickel refinery. Int Arch Occup Environ Health 1998;71:245-250
2. Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, Heikkilä P, Wanders S, Wilhardt P, Hansteen IL, Knudsen L E, Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 2000; 60:1619-1625
3. Case C P, Langkamer V G, James C, Palmer M R, Kemp A J, Heap P F, Solomon L. Widespread dissemination of metal debris from implants. J Bone Joint Surg (Br) 1994; 76: 701-712
4. Case C P, Langkamer V G, Howell R T, Webb J, Standen G, Palmer M, Kemp A, Learmonth I D. Preliminary observations on possible premalignant changes in bone marrow adjacent to worn total hip arthroplasty implants. Clin Orthop 1996; 329 (Suppl) S: 269-279
5. Coen N, Kadhim M A, Wright E G, Case C P, Mothersill C E. Particulate debris from a titanium metal prosthesis induces genomic instability in primary human fibroblast cells. Br J Cancer 2003; 88:548-552
6. Cooper C, Inskip H, Croft P, Campbell L, Smith G, McLaren M, Coggon D. Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol 1998; 15;147: 516-522
7. Daley B, Doherty A T, Fairman B, Case C P. Wear debris from hip or knee replacements causes chromosomal damage in human cells in tissue culture. J Bone Joint Surg (Br) 2004; 86:598-606.
8. Davies A P, Sood A, Lewis A C, Newson R, Learmonth I D, Case C P. Metal-specific differences in levels of DNA damage caused by synovial fluid recovered at revision arthroplasty. J Bone Joint Surg (Br) 2005; 87:1439-1444
9. Doherty A T, Howell R T, Ellis L A, Bisbinas I, Learmonth I D, Newson R, Case C P. Increased chromosome translocations and aneuploidy in peripheral blood lymphocytes of patients having revision arthroplasty of the hip. J Bone Joint Surg (Br) 2001; 83: 1075-1081
10. Engh CA Jr, Moore K D, Vinh T N, Engh G A. Titanium prosthetic wear debris in remote bone marrow. A report of two cases. J Bone Joint Surg (Am) 1997; 79:1721-1725
11. Gatti G M, Ivaldi G B, Lartigau E, Marsiglia H, Orecchia R. A case of rhabdomyosarcoma following metal surgical implant. Sarcoma 1999; 3:145-147
12. Gillespie W J, Frampton C M, Henderson R J, Ryan P M. The incidence of cancer following total hip replacement. J Bone Joint Surg (Br): 1988; 70: 539-42. Erratum in: J Bone Joint Surg (Br) 1996; 78: 680.
13. Goldacre M J, Wotton C J, Seagroatt V, Yeates D. Cancer following hip and knee arthroplasty: record linkage study. Br J Cancer 2005; 92: 1298-1301
14. Granchi D, Savarino L, Ciapetti G, Cenni E, Rotini R, Mieti M, Baldini N, Giunti A. Immunological changes in patients with primary osteoarthritis of the hip after total joint replacement. J Bone Joint Surg (Br) 2003; 85: 758-764
15. Hsieh T C, Kao C H, Yen K Y, Sun S S. Osteomyelitis-mimicking primary bone lymphoma at hip prosthetic site. Clin Nucl Med 2007; 32: 543-544
16. Jacobs J J, Skipor A K, Patterson L M, Hallab N J, Paprosky W G, Black J, Galante J O. Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg (Am) 1998; 80: 1447-1458
17. Järvholm B, Lewold S, Malchau H, Vingard E. Age, bodyweight, smoking habits and the risk of severe osteoarthritis in the hip and knee in men. Eur J Epidemiol 2005; 20: 537-542
18. Langkamer V G, Case C P, Heap P, Taylor A, Collins C, Pearse M, Solomon L. Systemic distribution of wear debris after hip replacement. A cause for concern. J Bone Joint Surg (Br) 1992; 74: 831-839
19. Lucas DR, Miller PR, Mott MP, Kronick JL, Unni KK. Athroplasty-associated malignant fibrous histiocytoma: two case reports. Histopathology 2001; 39:620-628 Review.
20. MacDonald S J, McCalden R W, Chess D G, Bourne R B, Rorabeck C H, Cleland D, Leung F. Metal-on-metal versus polyethylene in hip arthroplasty: a randomized clinical trial. Clin Orthop 2003; (406): 282-296
21. Min W K, Kim S Y, Oh C W Kim S J, Park T I, Koo K H. Malignant fibrous histiocytoma arising in the area of total hip replacement. J Bone Spine 2008; 75: 319-321
22. Nevalainen J, Hirvonen A, Pulkkinen P. The 1998-1999 implant yearbook on orthopaedic endoprostheses. Publication of the National Agency for Medicines, Helsinki 5/2000.
23. Onega T, Baron J, MacKenzie T. Cancer after total joint arthroplasty: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1532-1537
24. Paavolainen P, Pukkala E, Pulkkinen, Visuri, T. Cancer incidence in Finnish hip replacement patients from 1980 to 1995. A nationwide cohort study involving 31,651 patients. J. Arthroplasty 1999; 14: 272-80. Erratum 2000; 15: 136-137 (Pubitemid 29172241)
25. Papageorgiou I, Shadrick V, Davis S, Hails L, Schins R, Newson R, Fisher J, Ingham E, Case C P. Macrophages detoxify the genotoxic and cytotoxic effects of surgical cobalt chrome alloy particles but not quartz particles on human cells in vitro. Mutat Res 2008; 643(1-2): 11-19
26. Rasquinha V J, Ranawat C S, Weiskopf J, Rodriguez J A, Skipor A K, Jacobs J J. Serum metal levels and bearing surfaces in total hip arthroplasty. J Arthroplasty 2006; 21(6 Suppl 2): 47-52.
27. Reynolds M, Peterson E, Quievryn G, Zhitkovich A. Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J Biol Chem 2004; 279: 30419-30424
28. Savarino L, Granchi D, Ciapetti G, Cenni E, Nardi Pantoli A, Rotini R, Veronesi C A, Baldini N, Giunti A. Ion release in patients with metal-on-metal hip bearings in total joint replacement: a comparison with metal-on-polyethylene bearings. J Biomed Mater Res 2002; 63: 467-474
29. Schuh A, Zeiler G, Holzwarth U, Aigner T. Malignant fibrous histiocytoma at the site of a total hip arthroplasty. Cin Orthop 2004; (425): 218-222, Review.
30. Shea K G, Lundeen G A, Bloebaum R D, Bachus K N, Zou L. Lymphoreticular dissemination of metal particles after primary joint replacements. Clin Orthop 1997; (338): 219-226
31. Stea S, Visentin M, Granchi D, Savarino L, Dallari D, Gualtieri G, Rollo G, Toni A, Pizzoferrato A, Montanaro L. Sister chromatid exchange in patients with joint prosthesis. J Arthroplasty 2000; 15: 772-777
32. Thomas E, Brewster D H, Black R J, Macfarlane G J. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000; 88: 497-502.
33. Tyczynski J E, Bray F, Parkin D M. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol 2003; 4: 45-55, Review. Erratum in: Lancet Oncol 2003; 4: 396.
34. Urban R M, Jacobs J J, Tomlinson M J, Gavrilovic J, Black J, Peoc'h M. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg (Am) 2000; 82: 457-476
35. Urban R M, Tomlinson M J, Hall D J, Jacobs J J. Accumulation in liver and spleen of metal particles generated at nonbearing surfaces in hip arthroplasty. J Arthroplasty 2004; 19 (Suppl 3): 94-101.
36. Vingård E, Alfredsson L, Malchau H. Lifestyle factors and hip arthrosis. A case referent study of body mass index, smoking and hormone therapy in 503 Swedish women. Acta Orthop Scand 1997; 68: 216-220
37. Visuri T, Pukkala E, Pulkkinen P, Paavolainen P. Decreased cancer risk in patients who have been operated on with total hip and knee arthroplasty for primary osteoarthrosis: a meta-analysis of 6 Nordic cohorts with 73,000 patients. Acta Orthop Scand 2003; 74: 351-360
38. Visuri T, Koskenvuo M. Cancer risk after Mckee-Farrar total hip replacement. Orthopedics 1991; 14: 137-142
39. Visuri T, Pulkkinen P, Paavolainen P. Malignant tumors at the site of total hip prosthesis. Analytic review of 46 cases. J Arthroplasty 2006; 21: 311-323
40. zur Hausen H. Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta 1996; 1288: F55-78, Review. (Pubitemid 26335492)
41. Yates D H, Corrin B, Stidolph P N, Browne K. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases Thorax 1997; 52: 507-12, Erratum Thorax 1997; 52: 1018.